Molecular Diagnostics

Yenos Analytical Launches Multi-Cancer Early Detection Urine Test

The direct-to-consumer laboratory-developed test detects six cancer types with 97% sensitivity and specificity using microRNA biomarkers, according to the company.

Molecular Diagnostics

SOPHiA GENETICS Partners With Element Biosciences to Integrate AI Analytics With NGS Systems

The collaboration combines SOPHiA's DDM platform with Element's AVITI sequencing systems to streamline genomic workflows for precision medicine research.

Molecular Diagnostics

IDT Partners with Profluent Bio to Develop AI-Designed Enzymes

The collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.

New Automated Target Enrichment Protocols Support High-Throughput Genomic Workflows

Oct 8, 2025 | Molecular Diagnostics

The optimized protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kit for clinical research and precision medicine applications.

Long-Read Sequencing Provider Adds Oxford Nanopore Assays

Oct 7, 2025 | Molecular Diagnostics

Wasatch BioLabs expands service portfolio with pharmacogenomics panel, telomere sequencing, and mRNA vaccine quality control workflows.

Preeclampsia Foundation Releases Educational Resources on Predictive Testing

Oct 7, 2025 | Molecular Diagnostics

New materials aim to help patients and providers understand emerging molecular diagnostic tools for hypertensive disorders of pregnancy.

US Genomic Newborn Screening Initiative Launches with $14.4 Million NIH Award

Oct 7, 2025 | Molecular Diagnostics

BEACONS, a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in US newborn screening.

Hitachi High-Tech, ELITech Partner on Automated PCR Testing Platform

Sep 26, 2025 | Molecular Diagnostic Analyzers

The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.

Ultima Genomics’ ppmSeq Technology Shows Ultra-Low Error Rates for MRD Detection

Sep 26, 2025 | Sequencing Systems

New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.

bioMérieux Receives FDA Clearance for Anterior Nasal Swab Testing on Spotfire Platform

Sep 25, 2025 | Amplification Technologies

The French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.

Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics

Sep 24, 2025 | Molecular Diagnostic Analyzers

The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.

Myriad Genetics, SOPHiA GENETICS Partner on Global Liquid Biopsy Companion Diagnostic

Sep 24, 2025 | Molecular Diagnostic Analyzers

The collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.

Seegene, Springer Nature Launch $600K Grant Program for UTI Antibiotic Resistance Research

Sep 23, 2025 | Amplification Technologies

The program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.

PacBio Launches HiFi Sequencing Platform for Carrier Screening Market

Sep 22, 2025 | Sequencing Systems

The updated solutions leverage PacBio’s HiFi sequencing technology to allow clinical laboratories to consolidate multiple specialized assays into a single, scalable test.

Enhanced PCR Reporting Service Applies CLSI Guidelines to UTI Results

Sep 18, 2025 | Molecular Diagnostic Analyzers

The service applies CLSI M100 guidelines to PCR reports, delivering insights on pathogens and resistance markers to support labs and physicians.

Rare Disease Test Expanded to Include Tandem Repeat and Mitochondrial Analysis

Sep 18, 2025 | Sequencing Systems

The expanded testing capabilities leverage long-read sequencing technology to detect disorders such as Fragile X syndrome, adult neurological conditions, certain ataxias, and more.